SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biogen Says Diranersen Showed Clinical Benefits Across Studied Doses

Biogen said the 60 mg dose group showed compelling efficacy and a favorable benefit-risk profile.

BIIB

Related stories